Chelator-mediated iron efflux from reticulocytes

Area of Science:

• Cell Biology
• Biochemistry
• Hematology

Background:

• Iron uptake by developing erythroid cells is crucial for hemoglobin synthesis.
• Transferrin is the primary iron transport protein in circulation.
• Understanding iron metabolism regulation is key to treating iron-related disorders.

Purpose of the Study:

• Investigate the mechanism of iron chelators (bipyridine, phenanthroline) on iron uptake and efflux.
• Elucidate the role of these chelators in iron metabolism within erythroid cells.
• Provide insights into normal iron uptake processes in developing red blood cells.

Main Methods:

• Utilized rabbit reticulocytes to study iron uptake and efflux mechanisms.
• Employed iron chelators (bipyridine, phenanthroline) and pyridoxal isonicotinoyl hydrazone.
• Measured diethyl ether/water partition coefficients to assess lipid solubility and membrane permeability.

Main Results:

• Chelators inhibit iron uptake by binding iron released from transferrin within the cell membrane.
• Iron-chelator complexes are released from cells via exocytosis, similar to transferrin.
• Chelators block iron efflux from isoniazid-treated cells by binding intracellular and mitochondrial iron, preventing release.

Conclusions:

• Iron chelators interfere with cellular iron uptake and efflux through distinct mechanisms.
• Exocytosis plays a significant role in the release of iron-chelator complexes from cells.
• Differences in lipid solubility explain the intracellular trapping of iron by chelators.